Nutex Health, Inc.

NASDAQ:NUTX

Medical - Healthcare Information Services

Healthcare
$172.74 +1.94%

+$2.84 today

Market cap
$1.19B
Beta
2.06
P/E (TTM)
10.4
EPS (TTM)
$14.38
52W Low $77.21High $193.07

Volume 0.16M

Average 0.17M

NUTX Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Nutex Health, Inc.NASDAQ: NUTX

Net Margin · Q1 FY2026 · quarter ended Mar 2026

Net margin widens to 21.6%

Net margin was 21.6% in Q1 FY2026, up 14.7 pp from a year earlier. On a trailing-twelve-month basis it was 11.0%, up 0.2 pp year over year. Over 3 fiscal years it widened by 201.8 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 4 analysts of 21.4% for the fiscal year ending Dec 2026, up from 8.1% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
21.6%+13.8 pp QoQ
Last fiscal yearDec 2025
8.1%-2.8 pp YoY
LTMMar 2026
11.0%+0.2 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+14.7 pp+23.5 pp+8.8 pp
1 year-2.8 pp+13.3 pp+16.1 pp
3 years+201.8 pp+10.2 pp-191.6 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
8.1%
Year-over-year change
-2.8pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How NUTX compares with its peers on the latest reported figures

  • NUTX's LTM Mar 2026 net margin of 11.0% is the highest of the 11 companies compared; the peer median is 1.5%.
  • Its year-over-year change of +0.2 pp is the 8th highest of 11, against a peer median of +1.1 pp.
  • Over three fiscal years its change of +201.8 pp compares with a peer median of -0.9 pp.
NUTX Competitors Peer median
Net Margin for NUTX and competitors
Company Period LTM level YoY 3-year change
NUTXNutex Health, Inc.LTM Mar 202611.0% +0.2 pp+201.8 pp
THCTenet Healthcare CorporationLTM Jun 202610.3% +3.1 pp+4.5 pp
EHCEncompass Health CorporationLTM Jun 202610.0% +0.8 pp+3.3 pp
CONConcentra Group Holdings Parent, Inc.LTM Sep 20269.3% +1.9 pp-2.0 pp
UHSUniversal Health Services, Inc.LTM Jun 20268.4% +0.8 pp+3.5 pp
ARDTArdent Health Partners, LLCLTM Mar 20262.1% -1.6 pp-1.5 pp
ASTHAstrana Health, Inc.LTM Mar 20260.9% -0.7 pp-3.2 pp
CYHCommunity Health Systems, Inc.LTM Mar 2026-0.4% +3.4 pp+3.7 pp
INNVInnovAge Holding Corp.LTM Mar 2026-2.3% +1.4 pp-2.6 pp
SGRYSurgery Partners, Inc.LTM Sep 2026-2.6% +2.6 pp-0.2 pp
AGLAgilon Health, Inc.LTM Mar 2026-6.4% -2.4 pp-2.4 pp
Peer median (excluding NUTX) 1.5%+1.1 pp-0.9 pp

Competitors are the stored peer set for NUTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue331.53M219.29M247.65M479.95M875.26M
Cost of Revenue152.25M203.87M212.87M283.69M430.98M
Gross Profit179.28M15.42M34.77M196.26M444.28M
Gross Margin54.1%7.0%14.0%40.9%50.8%
Research & Development285.88K0000
Selling, General & Admin5.46M20M36.07M58.56M168.66M
Operating Expenses9.02M422.02M66.55M65.64M168.66M
Depreciation & Amortization7.76M13.13M17.59M18.97M20.53M
EBITDA183.45M(394.03M)(14.58M)148.65M287.54M
EBITDA Margin55.3%-179.7%-5.9%31.0%32.9%
Operating Income170.26M(406.6M)(31.77M)130.62M275.63M
Operating Margin51.4%-185.4%-12.8%27.2%31.5%
Interest Income00000
Interest Expense6.2M12.49M16.32M19.93M22.23M
Other Income / Expenses(773.88K)(13.05M)(16.72M)(20.87M)(30.84M)
Income Before Tax169.49M(419.65M)(48.49M)109.75M244.78M
Pre-Tax Margin51.1%-191.4%-19.6%22.9%28.0%
Income Tax Expense965.73K13.09M(5.07M)14.48M64.42M
Net Income132.59M(424.78M)(45.79M)52.18M70.79M
Net Margin40.0%-193.7%-18.5%10.9%8.1%
EPS (Basic)33.55(100.50)(10.39)10.2311.13
EPS (Diluted)33.55(100.36)(10.39)9.7110.48
Weighted Avg Shares4.02M4.23M4.41M5.1M6.36M
Weighted Avg Shares (Diluted)3.95M4.23M4.41M5.1M6.76M

Nutex Health, Inc.

NASDAQ:NUTX

Intrinsic Alpha fair value

Locked

Current Price

$172.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.